117 related articles for article (PubMed ID: 38354331)
21. Frontline treatment patterns and attrition rates by subsequent lines of therapy in patients with newly diagnosed multiple myeloma.
Fonseca R; Usmani SZ; Mehra M; Slavcev M; He J; Cote S; Lam A; Ukropec J; Maiese EM; Nair S; Potluri R; Voorhees PM
BMC Cancer; 2020 Nov; 20(1):1087. PubMed ID: 33172403
[TBL] [Abstract][Full Text] [Related]
22. Associations Between Social Risk Factors and Surgical Site Infections After Colectomy and Abdominal Hysterectomy.
Qi AC; Peacock K; Luke AA; Barker A; Olsen MA; Joynt Maddox KE
JAMA Netw Open; 2019 Oct; 2(10):e1912339. PubMed ID: 31577353
[TBL] [Abstract][Full Text] [Related]
23. Disparities in Care Management During Terminal Hospitalization Among Adults With Metastatic Cancer From 2010 to 2017.
Deeb S; Chino FL; Diamond LC; Tao A; Aragones A; Shahrokni A; Yerramilli D; Gillespie EF; Tsai CJ
JAMA Netw Open; 2021 Sep; 4(9):e2125328. PubMed ID: 34550384
[TBL] [Abstract][Full Text] [Related]
24. Elotuzumab and Weekly Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Without Transplant Intent: A Phase 2 Measurable Residual Disease-Adapted Study.
Derman BA; Kansagra A; Zonder J; Stefka AT; Grinblatt DL; Anderson LD; Gurbuxani S; Narula S; Rayani S; Major A; Kin A; Jiang K; Karrison T; Jasielec J; Jakubowiak AJ
JAMA Oncol; 2022 Sep; 8(9):1278-1286. PubMed ID: 35862034
[TBL] [Abstract][Full Text] [Related]
25. Carfilzomib or bortezomib in combination with lenalidomide and dexamethasone for patients with newly diagnosed multiple myeloma without intention for immediate autologous stem-cell transplantation (ENDURANCE): a multicentre, open-label, phase 3, randomised, controlled trial.
Kumar SK; Jacobus SJ; Cohen AD; Weiss M; Callander N; Singh AK; Parker TL; Menter A; Yang X; Parsons B; Kumar P; Kapoor P; Rosenberg A; Zonder JA; Faber E; Lonial S; Anderson KC; Richardson PG; Orlowski RZ; Wagner LI; Rajkumar SV
Lancet Oncol; 2020 Oct; 21(10):1317-1330. PubMed ID: 32866432
[TBL] [Abstract][Full Text] [Related]
26. Are Detailed, Patient-level Social Determinant of Health Factors Associated With Physical Function and Mental Health at Presentation Among New Patients With Orthopaedic Conditions?
Bernstein DN; Lans A; Karhade AV; Heng M; Poolman RW; Schwab JH; Tobert DG
Clin Orthop Relat Res; 2023 May; 481(5):912-921. PubMed ID: 36201422
[TBL] [Abstract][Full Text] [Related]
27. Triplet RVd Induction for Transplant-Eligible Newly Diagnosed Multiple Myeloma: A Systematic Review and Meta-Analysis.
Yang G; Geng C; Jian Y; Zhou H; Chen W
Adv Ther; 2022 Aug; 39(8):3799-3834. PubMed ID: 35771352
[TBL] [Abstract][Full Text] [Related]
28. Trends, Sociodemographic and Hospital-Level Factors Associated With Palliative Care Utilization Among Multiple Myeloma Patients Using the National Inpatient Sample (2016-2018).
Jackson I; Jackson N; Etuk A
Am J Hosp Palliat Care; 2022 Aug; 39(8):888-894. PubMed ID: 34663083
[TBL] [Abstract][Full Text] [Related]
29. Medicaid insurance as primary payer predicts increased mortality after total hip replacement in the state inpatient databases of California, Florida and New York.
Xu HF; White RS; Sastow DL; Andreae MH; Gaber-Baylis LK; Turnbull ZA
J Clin Anesth; 2017 Dec; 43():24-32. PubMed ID: 28972923
[TBL] [Abstract][Full Text] [Related]
30. Insurance-and race-related disparities decrease in elderly trauma patients.
Singer MB; Liou DZ; Clond MA; Bukur M; Mirocha J; Margulies DR; Salim A; Ley EJ
J Trauma Acute Care Surg; 2013 Jan; 74(1):312-6. PubMed ID: 23147178
[TBL] [Abstract][Full Text] [Related]
31. Association of Race, Health Insurance Status, and Household Income With Location and Outcomes of Ambulatory Surgery Among Adult Patients in 2 US States.
Janeway MG; Sanchez SE; Chen Q; Nofal MR; Wang N; Rosen A; Dechert TA
JAMA Surg; 2020 Dec; 155(12):1123-1131. PubMed ID: 32902630
[TBL] [Abstract][Full Text] [Related]
32. Racial and insurance based disparities in the treatment of carotid artery stenosis: a study of the Nationwide Inpatient Sample.
Brinjikji W; El-Sayed AM; Kallmes DF; Lanzino G; Cloft HJ
J Neurointerv Surg; 2015 Sep; 7(9):695-702. PubMed ID: 25015114
[TBL] [Abstract][Full Text] [Related]
33. Underutilization of guideline-recommended supportive care among older adults with multiple myeloma in the United States.
Giri S; Zhu W; Wang R; Zeidan A; Podoltsev N; Gore SD; Neparidze N; Ma X; Gross CP; Davidoff AJ; Huntington SF
Cancer; 2019 Nov; 125(22):4084-4095. PubMed ID: 31381151
[TBL] [Abstract][Full Text] [Related]
34. Race, Insurance, and Sex-Based Disparities in Access to High-Volume Centers for Pancreatectomy.
Williamson CG; Ebrahimian S; Sakowitz S; Aguayo E; Kronen E; Donahue TR; Benharash P
Ann Surg Oncol; 2023 May; 30(5):3002-3010. PubMed ID: 36592257
[TBL] [Abstract][Full Text] [Related]
35. Treatment at Academic Centers Decreases Insurance-Based Survival Disparities in Colon Cancer.
Cabo J; Shu X; Shu XO; Parikh A; Bailey C
J Surg Res; 2020 Jan; 245():265-272. PubMed ID: 31421372
[TBL] [Abstract][Full Text] [Related]
36. A budget impact analysis of lenalidomide in multiple myeloma Egyptian patients.
Elsisi GH; Carapinha JL; Afify R; Elmoty MA; Khalaf M
J Med Econ; 2020 Oct; 23(10):1168-1175. PubMed ID: 32669063
[TBL] [Abstract][Full Text] [Related]
37. Carfilzomib, lenalidomide, dexamethasone, and cyclophosphamide (KRdc) as induction therapy for transplant-eligible, newly diagnosed multiple myeloma patients (Myeloma XI+): Interim analysis of an open-label randomised controlled trial.
Jackson GH; Pawlyn C; Cairns DA; de Tute RM; Hockaday A; Collett C; Jones JR; Kishore B; Garg M; Williams CD; Karunanithi K; Lindsay J; Rocci A; Snowden JA; Jenner MW; Cook G; Russell NH; Drayson MT; Gregory WM; Kaiser MF; Owen RG; Davies FE; Morgan GJ;
PLoS Med; 2021 Jan; 18(1):e1003454. PubMed ID: 33428632
[TBL] [Abstract][Full Text] [Related]
38. Lenalidomide as maintenance treatment for patients with multiple myeloma after autologous stem cell transplantation: A pharmaco-economic assessment.
Uyl-de Groot CA; Ramsden R; Lee D; Boersma J; Zweegman S; Dhanasiri S
Eur J Haematol; 2020 Nov; 105(5):635-645. PubMed ID: 32705720
[TBL] [Abstract][Full Text] [Related]
39. The clinical management of lenalidomide-based therapy in patients with newly diagnosed multiple myeloma.
Merz M; Dechow T; Scheytt M; Schmidt C; Hackanson B; Knop S
Ann Hematol; 2020 Aug; 99(8):1709-1725. PubMed ID: 32296915
[TBL] [Abstract][Full Text] [Related]
40. Clinical characteristics, treatment patterns, and outcomes among African American and White patients with multiple myeloma in the United States.
Saunders A; Slaff S; Subbiah K; Gu T; Ang KK; Quan MA; Rosenberg AS
Leuk Lymphoma; 2024 Jan; 65(1):109-117. PubMed ID: 37917858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
